Ledger.Open graph →
SEC Form D · filed December 23, 2020

Atsena Therapeutics, Inc

Offering
$55.0M
Sold
$27.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DURHAM, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Patrick Ritschel · Durham, NCExec · DirectorShannon Boye · Durham, NCDirectorMichael Dial · Durham, NCDirectorBenjamin Yerxa · Durham, NCDirectorSanford Boye · Durham, NCExecDaniel W. Landry · El Segundo, CAExecEmily W. Fairbairn · Foster City, CADirectorKeith W. Archer · Foster City, CADirectorAnkur W. Desai · El Segundo, CADirectorRichard W. Libretti · Morristown, NJExec · DirectorHemant Y. Taneja · Cambridge, MAExecHirsh B. Hirsh · Blacklick, OHDirectorEli Blee-Goldman · Milwaukee, WIDirectorJohn Zeratsky · Milwaukee, WIDirectorHoward Hall · Boston, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗